Arthritis discovery

The use of steroids could benefit thousands of arthritis sufferers, according to the results of an Pounds 85,000 research and clinical trial programme at Bristol University.

In the 1950s, high doses of steroids were used to treat the symptoms of advanced rheumatoid arthritis. This approach was abandoned because dangerous side-effects emerged.

But John Kirwan of Bristol University's Rheumatology Unit was convinced that low doses of corticosteroids could be effective.

In partnership with Margaret Byron of Stoke Mandeville Hospital, he developed a low-dose strategy and began clinical trials with 128 volunteer patients. Half were given the daily steroid pill, with the remainder receiving a placebo.

After it had been monitored for two years, it emerged that those on the low dose of corticosteroids had less bone and tissue damage. They also found that the underlying disease had been reduced.

"The exciting thing about the result is that we now have the hope of controlling the disease long term," he said. The study was financed by the Arthritis and Rheumatism Council.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Register to continue  

You've enjoyed reading five THE articles this month. Register now to get five more, or subscribe for unrestricted access.

Most Commented

  • Woman taking homeopathic medicine

Alternative treatments in healthcare plan is latest in a series of homeopathy-related controversies

  • Man lying beneath rugby pile-up

Six academics share their experiences before delivering a verdict on the system

  • Zygmunt Bauman with hand over mouth

Eminent sociologist has recycled 90,000 words of material across a dozen books, claims paper

  • Sorana Vieru, National Union of Students

Sorana Vieru says exams and essays 'privilege' more advantaged students, calls for changes to 'Middle Ages' format

  • Andrew Fire receives Nobel Prize in Physiology or Medicine, 2006

UK is second to US for nationality of Nobel prizewinners in the 21st century